Industries > Pharma > Brazilian Pharmaceutical Market Outlook 2017-2027

Brazilian Pharmaceutical Market Outlook 2017-2027

Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies

PUBLISHED: 18 August 2017
PAGES: 181
PRODUCT CODE: PHA0226

Clear
WOOCS 2.2.1

The Brazilian Pharmaceutical market was valued at $26.40bn in 2016. Visiongain forecasts this market to increase at a CAGR of 7.6% in the first half of the forecast period. Originator drugs held the largest market share in 2016, this trend however will change in the second half of the forecast period where we predicted that Generic drugs will take over the lead.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 181-page report you will receive 107 charts – all unavailable elsewhere.

The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Brazilian Pharmaceutical Market forecasts from 2017-2027

• Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment:
• Originator Drugs
• Generic Drugs
• OTC

Brazilian Pharmaceutical Market forecasts from 2017-2027, by therapeutic area:
• CNS
• Cardiovascular
• Gastrointestinal/Metabolic
• Oncology
• Infectious Disease

Brazilian Pharmaceutical Market Outlook 2017-2027

• Leading Domestic Companies in the Brazilian Pharmaceutical Market:
• EMS
• Hypermarcas
• Medley
• Eurofarma
• Aché
• Cristalia
• Teuto
• Libbs
• Biolab
• União Química

• Leading Multinational Companies in the Brazilian Pharmaceutical Market:
• Novartis
• Sanofi
• Roche
• Merck & Co.
• Pfizer
• Takeda
• Bayer
• GlaxoSmithKline
• Boehringer Ingelheim
• Astra Zeneca

SWOT and STEP Analysis of the Brazilian Pharmaceutical market

• This report also discusses:
• The Brazilian healthcare environment, covering important institutional bodies and agencies, surveying the regulatory system, analyzing the balance between public and private healthcare provision and looking at the wholesale and distribution landscape
Regional variations within Brazil, with profiles of each region and an analysis of their healthcare challenges and opportunities
Brazilian Biologics Market, which includes qualitative and quantitative analysis.

Visiongain’s study is intended for anyone requiring commercial analyses for the Brazilian Pharmaceutical market and the leading companies competing in that country. You find data, trends and predictions.

Buy our report today Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Brazilian Pharmaceutical Market Outlook 2017-2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories